OR WAIT null SECS
October 16, 2023
A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past.
August 22, 2023
The collaboration partner for Willow is focused on more sustainable methods to manufacture intermediates and APIs at reduced cost and less waste, in addition to looking for Willow’s expertise in developing and scaling key ingredients.
The deal is worth up to $36 million with an initial upfront consideration of $14 million, with an additional $22 million in contingent value rights (CVRs) that is payable upon achieving certain milestones.
July 02, 2023
Detection of nitrosamines in several commercial drugs has resulted in manufacturing batch recalls followed by a review of the APIs’ synthesis processes by MAHs.
June 03, 2023
What factors do CDMOs consider vital to their success?
March 08, 2023
Actylis new 30,000-ft² API manufacturing facility is located in Eugene, Ore.
January 18, 2023
Snapdragon Chemistry concentrates in API batch and continuous flow process development, utilizing state-of-the-art automation technology and proprietary equipment to solve complex process and analytical development challenges.
Agilent’s $725 million investment is designed to double its capacity to produce APIs.
October 25, 2022
Vibha Jawa, executive director at Bristol Myers Squibb, and Luke Schenck, principal scientist at Merck & Com, discuss cell & gene therapies and co-processed APIs respectively.
June 09, 2022
Following the acquisition by Altaris Capital Partners, Johnson Matthey Health has rebranded as Veranova.